← Back to Search

LAA Exclusion Device

VClip Post-Market Study

N/A
Waitlist Available
Led By Elias Zias, MD
Research Sponsored by AtriCure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months or greater post-procedure
Awards & highlights
No Placebo-Only Group

Summary

This trial studies two medical devices, AtriClip® FLEX-V LAA and PRO•V LAA, used to close off a small part of the heart called the left atrial appendage. The devices are tested on patients who are already undergoing other heart surgeries. By closing off this part of the heart, the devices help prevent blood clots and reduce the risk of stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months or greater post-procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months or greater post-procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Performance Endpoint
Primary Safety Endpoint
Secondary study objectives
Device and Procedure long-term Safety
Long-term thromboembolic events
Performance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AtriClip groupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

AtriCure, Inc.Lead Sponsor
42 Previous Clinical Trials
18,615 Total Patients Enrolled
Elias Zias, MDPrincipal InvestigatorNYU Langone Health

Media Library

AtriClip (LAA Exclusion Device) Clinical Trial Eligibility Overview. Trial Name: NCT05101993 — N/A
Left Atrial Appendage Absent Research Study Groups: AtriClip group
Left Atrial Appendage Absent Clinical Trial 2023: AtriClip Highlights & Side Effects. Trial Name: NCT05101993 — N/A
AtriClip (LAA Exclusion Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05101993 — N/A
~41 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top